@stocktitan.netOct 14, 2026, 11:05 AM #VKTK #VKTX Viking Therapeutics Announces Initiation of VK2735 Oral Phase 3 Clinical Program in Patients with Obesityhttps://www.stocktitan.net/news/VKTK/viking-therapeutics-announces-initiation-of-vk2735-oral-phase-3-xliho4plrwei.html?utm_source=stocktitan-bluesky&utm_medium=social
@stocktitan.net@stocktitan.net
@stocktitan.net